| Vol. 7.44 – 13 December, 2021 |
| |
|
|
| Researchers examined whether the inhibition of cell cycle with cyclin-dependent kinase (CDK) 4/6 inhibitor suppressed fibroblast proliferation and the differentiation into myofibroblasts, and the therapeutic effect of a CDK4/6 inhibitor on dermal fibrosis in murine models of systemic sclerosis. [Arthritis & Rheumatology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| DERMAL STEM CELLS & TISSUE REGENERATION |
|
|
|
| The authors investigated the mechanism underlying the protective effects of galangin against H2O2/UVB-induced damage using in vitro and in vivo models of photodamage. [Aging] |
|
|
|
| Investigators used a human skin organotypic culture model to characterize the deleterious effects of an acute topic exposure of human skin to moderately high concentrations of common ambient pollutants, including As, Cd, Cr, dioxins and tobacco smoke. [Scientific Reports] |
|
|
|
| Researchers reported the role of transglutaminase 2 (TG2) in mediating the UVB-induced expression of MMP-1. UVB-irradiation enhanced the expression and activity of TG2, which in turn promoted the expression of MMP-1. [Experimental Dermatology] |
|
|
|
| Scientists assessed the effect of metformin on hair growth in a mouse hair follicle reconstitution model generated by in vitro self-assembled 3D aggregates of epidermal and dermal cells and suggested that metformin could promote hair follicle regeneration. [Skin Pharmacology and Physiology] |
| |
|
|
| SRY-box transcription factor 10 (SOX10) mediates neural crest development and is required for melanoma cell growth. The authors investigated immune-related targets of SOX10 and observed positive regulation of herpesvirus entry mediator and carcinoembryonic-antigen cell-adhesion molecule 1. [Cell Reports] |
|
|
|
| Scientists investigated the role of NUMB in melanoma progression and its regulatory mechanism. Analysis of The Cancer Genome Atlas melanoma datasets revealed that high NUMB expression in melanoma tissues correlated with improved patient survival. [Journal of Investigative Dermatology] |
|
|
|
| The authors demonstrated that B19V-infected fibroblasts developed typical senescence features such as enlarged and flat-shaped morphology and senescence-associated beta-galactosidase activity similar to that observed in systemic sclerosis (SSc) skin fibroblasts. [Rheumatology] |
|
|
|
| Researchers showed that increasing NTF2 expression in WM983B metastatic melanoma cells reduced cell proliferation and motility while increasing apoptosis. They also demonstrated that increasing NTF2 expression in these cells significantly inhibited metastasis and prolonged survival of mice. [Scientific Reports] |
|
|
|
| In an in vitro model of fibrosis, investigators consistently observed the induction of the c-Rel subunit of NF-κB. Functional abrogation of c-Rel by siRNA resulted in diminished cell contractility of dermal fibroblasts in relaxed, but not in stressed 3D collagen matrices. [Archives of Dermatological Research] |
|
|
|
|
| The best clinical practices used by leading atopic dermatitis (AD) centers included the use of validated diagnostic criteria, established AD scoring tools including patient-reported outcome measures and electronic health records, the formation of multidisciplinary teams, and improved communication between health care providers and patients. [Dermatologic Therapy] |
|
|
|
|
| Pfizer, Inc. announced that the European Commission has approved the 100 mg and 200 mg doses of Cibinqo®, an oral, once-daily, Janus kinase 1 inhibitor, for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy. [Pfizer, Inc.] |
|
|
|
| The Melanoma Research Alliance (MRA) welcomes the US FDA decision to expand eligibility of Merck’s Keytruda to include patients with Stage IIB and IIC melanoma. [The Melanoma Research Alliance] |
|
|
|
|
| January 21 -23, 2022 Austin, Texas, United States |
|
|
|
|
|
| University Hospital of Lausanne – Lausanne, Vaud, Switzerland |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| Heidelberg University – Heidelberg, Germany |
|
|
|
| European Molecular Biology Laboratory – Heidelberg, Germany |
|
|
|
| H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States |
|
|
|
|